EP. 1: Diagnosis of Prostate CancerByNicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of NevadaSeptember 16th 2020
EP. 2: Genetic Counseling for Prostate Cancer ByNicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of NevadaSeptember 16th 2020
EP. 3: Impact of BRCA Mutations in Prostate CancerByNicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of NevadaSeptember 16th 2020
EP. 4: FDA Approved PARP Inhibitors for Prostate CancerByNicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of NevadaSeptember 16th 2020
EP. 5: Quality of Life With Prostate CancerByNicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of NevadaSeptember 16th 2020
EP. 6: Patient’s Role in Decision-Making for Prostate CancerByNicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of NevadaSeptember 16th 2020
EP. 7: The Future of PARP Inhibitors in Prostate CancerByNicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of NevadaSeptember 16th 2020
